Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
PRME
#2265
Prime Medicine, Inc. Common Stock
4.6
2
+7.94%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
+7.94%
Monthly Change
+6.21%
6 month change
+35.48%
Cambio anual
+87.04%
Cierres anteriores
4.2
8
Open
4.6
2
Bid
Ask
Low
4.6
2
High
4.6
2
Volumen
111
Markets
Acciones
Atención Sanitaria
PRME
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
Noticias
Vanda Pharmaceuticals (VNDA) Reports Q4 Loss, Lags Revenue Estimates
Prime Drink Group finalise la première clôture de son placement privé
Prime Drink Group completes first closing of private placement
Prime: Maintaining "Buy" On Solidified Catalysts For Wilson's Disease And Beyond
Prime Drink Group annonce un placement privé pour lever jusqu’à 5 millions $
Prime Drink Group announces private placement to raise up to $5 million
Goldman Sachs reiterates Early-Stage Biotech rating on Prime Medicine stock
Prime Medicine, Inc. (PRME) Reports Q3 Loss, Lags Revenue Estimates
Prime Medicine appoints Matthew Hawryluk as chief business officer
NovoCure (NVCR) Reports Q3 Loss, Tops Revenue Estimates
Prime Medicine Momentum Amid Pipeline Progress: Why I Choose To 'Hold' For Now (PRME)
L’ETF ARK de Cathie Wood ajuste son portefeuille avec des transactions clés